Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1962 3
1963 2
1966 3
1967 5
1968 3
1969 2
1970 3
1971 2
1973 2
1974 2
1975 6
1976 7
1977 1
1978 3
1979 12
1980 6
1981 11
1982 7
1983 20
1984 20
1985 15
1986 17
1987 15
1988 13
1989 16
1990 19
1991 13
1992 12
1993 15
1994 22
1995 16
1996 22
1997 12
1998 14
1999 17
2000 11
2001 10
2002 14
2003 12
2004 19
2005 21
2006 22
2007 22
2008 18
2009 18
2010 28
2011 22
2012 19
2013 28
2014 24
2015 25
2016 22
2017 27
2018 30
2019 35
2020 19
2021 33
2022 34
2023 51
2024 56
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

929 results

Results by year

Filters applied: . Clear all
Page 1
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.
Nakamura Y, Mizuno N, Sunakawa Y, Canon JL, Galsky MD, Hamilton E, Hayashi H, Jerusalem G, Kim ST, Lee KW, Kankeu Fonkoua LA, Monk BJ, Nguyen D, Oh DY, Okines A, O'Malley DM, Pohlmann P, Reck M, Shin SJ, Sudo K, Takahashi S, Van Marcke C, Yu EY, Groisberg R, Ramos J, Tan S, Stinchcombe TE, Bekaii-Saab T. Nakamura Y, et al. Among authors: sudo k. J Clin Oncol. 2023 Dec 20;41(36):5569-5578. doi: 10.1200/JCO.23.00606. Epub 2023 Sep 26. J Clin Oncol. 2023. PMID: 37751561 Free PMC article. Clinical Trial.
Trop-2 expression and the tumor immune microenvironment in cervical cancer.
Chiba Y, Kojima Y, Yazaki S, Yoshida H, Takamizawa S, Kitadai R, Saito A, Okuma HS, Nishikawa T, Shimoi T, Sudo K, Noguchi E, Uno M, Ishikawa M, Kato T, Fujiwara Y, Yonemori K. Chiba Y, et al. Among authors: sudo k. Gynecol Oncol. 2024 Aug;187:51-57. doi: 10.1016/j.ygyno.2024.04.022. Epub 2024 May 8. Gynecol Oncol. 2024. PMID: 38723340
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study.
Koyama T, Shimizu T, Kojima Y, Sudo K, Okuma HS, Shimoi T, Ichikawa H, Kohsaka S, Sadachi R, Hirakawa A, Yoshida A, Ando RM, Ueno T, Yanagaki M, Matsui N, Nakamura K, Yamamoto N, Yonemori K. Koyama T, et al. Among authors: sudo k. Cancer Discov. 2023 Aug 4;13(8):1814-1825. doi: 10.1158/2159-8290.CD-23-0419. Cancer Discov. 2023. PMID: 37369013 Clinical Trial.
A paralysed thumb.
Sudo K, Kishimoto R, Tajima Y, Matsumoto A, Tashiro K. Sudo K, et al. Lancet. 2004 Apr 24;363(9418):1364. doi: 10.1016/S0140-6736(04)16047-9. Lancet. 2004. PMID: 15110494 No abstract available.
Prospective multicenter surveillance study of branch-duct intraductal papillary mucinous neoplasm of the pancreas; risk of dual carcinogenesis.
Ohtsuka T, Maguchi H, Tokunaga S, Hijioka S, Takayama Y, Koshita S, Hanada K, Sudo K, Uehara H, Tanno S, Tada M, Kimura W, Nakamura M, Kin T, Kamata K, Masamune A, Iwashita T, Akahoshi K, Ueki T, Okamura K, Kato H, Kumagi T, Kawabe K, Yoshida K, Mukai T, Sakagami J, Hirono S, Abue M, Nakafusa T, Morita M, Shimosegawa T, Tanaka M; Japan Pancreas Society IPMN Prospective Surveillance Group. Ohtsuka T, et al. Among authors: sudo k. Pancreatology. 2024 Nov;24(7):1141-1151. doi: 10.1016/j.pan.2024.08.013. Epub 2024 Aug 22. Pancreatology. 2024. PMID: 39191596 Free article.
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
Aiba H, Kojima Y, Shimoi T, Sudo K, Yazaki S, Imai T, Yoshida A, Iwata S, Kobayashi E, Kawai A, Arakawa A, Ogawa C, Kimura H, Yonemori K. Aiba H, et al. Among authors: sudo k. Jpn J Clin Oncol. 2023 Jun 29;53(7):604-610. doi: 10.1093/jjco/hyad031. Jpn J Clin Oncol. 2023. PMID: 37093679 Review.
Hyperthyroidism-associated chorea.
Sudo K, Tashiro K. Sudo K, et al. Lancet. 1998 Jul 18;352(9123):239. doi: 10.1016/S0140-6736(05)77847-8. Lancet. 1998. PMID: 9683244 No abstract available.
Characterization of novel, severely immunodeficient PrkdcΔex57/Δex57 mice.
Takagi Y, Sudo K, Yamaguchi S, Urata S, Ohno T, Hirose S, Matsumoto K, Kuramoto T, Serikawa T, Yasuda J, Ikutani M, Nakae S. Takagi Y, et al. Among authors: sudo k. Biochem Biophys Res Commun. 2023 Oct 20;678:193-199. doi: 10.1016/j.bbrc.2023.08.055. Epub 2023 Aug 26. Biochem Biophys Res Commun. 2023. PMID: 37651888 Free article.
929 results